FolioLanternBeta
PTCTPtc Therapeutics, Inc.

Eric Pauwels

Chief Business Officer at Ptc Therapeutics, Inc., as of Jun 12, 2026Sold $7.5M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
99K
shares sold, past 12 months
10
days with sales
$3.0M
largest single day, Dec 17, 2025
1
company filed for

Share of stake sold and shares held at Ptc Therapeutics, Inc. are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDec 2025: $4.9M under a disclosed plan$4.9MDecJan 2026: $808K under a disclosed planJanFeb 2026: $209K under a disclosed planFebMarAprMayJun 2026: $1.6M under a disclosed planJunJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Ptc Therapeutics, Inc. (PTCT)Chief Business OfficerApr 17, 2020Jun 12, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.